MRNA Moderna, Inc.: institutional ownership and insider trading
917 funds reported holding $27.4B of Moderna, Inc. in their latest 13F filings; in Q2 2026 funds net sold $523M, with 136 new positions and 84 funds selling out; over the last 12 months insiders bought $0 and sold $81.6M on the open market.
Famous investors holding MRNA
- Two Sigma (Two Sigma Investments): $507M, 0.4% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $201M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $436M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $51.0M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $807K, 0.0% of the portfolio
Largest institutional holders of MRNA
- FMR LLC — $3.63B
- BlackRock, Inc. (BLK) — $2.14B
- VANGUARD CAPITAL MANAGEMENT LLC — $1.63B
- Capital World Investors — $1.56B
- BAILLIE GIFFORD & CO — $1.28B
- VANGUARD GROUP INC — $1.23B
- STATE STREET CORP (STT, STT-PG) — $1.10B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.09B
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $734M
- GEODE CAPITAL MANAGEMENT, LLC — $679M
Recent MRNA insider trades
- Oct 15, 2026: Hoge Stephen sold 78,369 shares ($17.0M)
- Sep 15, 2026: Hoge Stephen sold 80,575 shares ($11.7M)
- Sep 10, 2026: Mock James M sold 34,836 shares ($4.69M)
- Sep 1, 2026: Klinger Shannon Thyme sold 3,471 shares ($486K)
Members of Congress trading MRNA
- Sep 24, 2026: Maria Elvira Salazar sold part of $1.00K–$15.0K
- Aug 19, 2026: Maria Elvira Salazar bought $1.00K–$15.0K
- Aug 19, 2026: Maria Elvira Salazar sold part of $1.00K–$15.0K
- Apr 8, 2025: Robert P. Bresnahan, Jr. sold $1.00K–$15.0K
- Feb 25, 2025: Robert P. Bresnahan, Jr. bought $1.00K–$15.0K
- Jan 15, 2025: Julie Johnson sold $1.00K–$15.0K
- Feb 1, 2024: Josh Gottheimer sold $1.00K–$15.0K
5%+ owners
- FMR LLC: 13.1% (Schedule 13G/A, filed Aug 6, 2026)
- Vanguard Capital Management: 6.5% (Schedule 13G, filed Apr 30, 2026)
- Capital World Investors: 5.6% (Schedule 13G, filed Aug 12, 2026)